亚洲美女福利-无码精品毛片波多野结衣-欧美成人精精品一区二区-羞羞动漫在线看免费-天天插日日干-亚洲精品丝袜日韩-久久久中精品2020中文-亚洲成肉网-久久日产一线二线三线suv-五月婷六月丁香狠狠躁狠狠爱-久久综合伊人中文字幕-亚洲欧洲日产喷水无码-国产免国产免‘费-九九九小视频-日韩av在线不卡

Cancer Primary Screening

DNA Methylation Detection Kit for Human SDC2, SEPTIN9 and TFPI2 Gene -- COLC (Colorectal Cancer)

Clinical Application

    Colorectal cancer (CRC) affects millions of people worldwide. It is unique in that it progresses slowly, making it 
    preventable, and mortality can be significantly reduced through early detection. Testing using stool samples is more appropriate for screening efforts than colonoscopy because it is easier to conduct the program. Simultaneous testing with FIT not only greatly improves sensitivity and specificity, but is also more acceptable for widespread screening, or home sampling.
     
    DNA Methylation can be a novel marker of prognosis for tumor therapy, which is also a reversible process in which inactivated tumor suppressor genes are expressed through demethylation to exert a tumor suppressor effect. Therefore, demethylation can be used as a new direction in cancer treatment to monitor the dynamics of the disease.

    Intended Use

    This kit is a real-time PCR assay for qualitative detection of DNA methylation in gene SDC2, SEPTIN9 and TFPI2 Gene in human genomic DNA extracted from stool sample.

    General Specification

    Methodology: Real-Time PCR, PCR-Fluorescence Probing

    Sample Type: Stool
    Analytical Sensitivity: 93.63%
    Analytical Specificity: 90.82%
    Precision: CV <5%
    LoD: 1% of  SDC2, SEPTIN9 and TFPI2 methylation in the background of 5 ng human genomic DNA

    Packing Specifications

    24 tests/kit (non-single test/tube)48 tests/kit (non-single test/tube)
     

    Work Flow



    Contact Us